» Articles » PMID: 17318488

Characterisation and Bioactivity of Protein-bound Polysaccharides from Submerged-culture Fermentation of Coriolus Versicolor Wr-74 and ATCC-20545 Strains

Overview
Specialty Biotechnology
Date 2007 Feb 24
PMID 17318488
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The protein-bound polysaccharides of Coriolus versicolor (CPS) have been reported to stimulate overall immune functions against cancers and various infectious diseases by activating specific cell functions. A New Zealand isolate (Wr-74) and a patented strain (ATCC-20545) of C. versicolor were compared in this study. The fruit bodies of both strains were grown for visual verification. Both strains were grown in submerged-culture using an airlift fermentor with milk permeate as the base medium supplemented with glucose, yeast extract and salt. Metabolic profiles of both strains obtained over 7-day fermentation showed very similar trends in terms of biomass production (8.9-10.6 mg/ml), amounts of extracellular polysaccharide (EPS) from the culture medium (1150-1132 microg/ml), and intracellular polysaccharide (IPS) from the mycelium (80-100 microg/ml). Glucose was the dominant sugar in both EPS and IPS, and the polymers each consisted of three molecular weight fractions ranging from 2 x 10(6) to 3 x 10(3 )Da. Both the EPS and IPS were able to significantly induce cytokine production (interleukin 12 and gamma interferon) in murine splenocytes in vitro. Highest levels of interleukin 12 (291 pg/ml) and gamma interferon (6,159 pg/ml) were obtained from samples containing Wr-74 IPS (0.06 microg/ml) and ATCC 20545 IPS (0.1 microg/ml), respectively. The results indicated that lower levels of EPS and IPS generally resulted in higher immune responses than did higher polymer concentrations.

Citing Articles

Characterization, In Vitro Biological Activity and In Vivo Cardioprotective Properties of (L.:Fr.) Quél. Heteropolysaccharides in a Rat Model of Metabolic Syndrome.

Nikolic M, Lazarevic N, Novakovic J, Jeremic N, Jakovljevic V, Zivkovic V Pharmaceuticals (Basel). 2023; 16(6).

PMID: 37375735 PMC: 10301780. DOI: 10.3390/ph16060787.


Bioactivity of Biomass and Crude Exopolysaccharides Obtained by Controlled Submerged Cultivation of Medicinal Mushroom .

Angelova G, Brazkova M, Mihaylova D, Slavov A, Petkova N, Blazheva D J Fungi (Basel). 2022; 8(7).

PMID: 35887493 PMC: 9319109. DOI: 10.3390/jof8070738.


(Synn. ) Polysaccharides in Cancer Therapy: Targets and Efficacy.

Habtemariam S Biomedicines. 2020; 8(5).

PMID: 32466253 PMC: 7277906. DOI: 10.3390/biomedicines8050135.


Nutritional Mushroom Treatment in Meniere's Disease with : A Rationale for Therapeutic Intervention in Neuroinflammation and Antineurodegeneration.

Scuto M, Di Mauro P, Ontario M, Amato C, Modafferi S, Ciavardelli D Int J Mol Sci. 2020; 21(1).

PMID: 31906226 PMC: 6981469. DOI: 10.3390/ijms21010284.


Factors affecting mushroom spp.

Bellettini M, Fiorda F, Maieves H, Lopes Teixeira G, Avila S, Hornung P Saudi J Biol Sci. 2019; 26(4):633-646.

PMID: 31048986 PMC: 6486501. DOI: 10.1016/j.sjbs.2016.12.005.


References
1.
Ho C, Lau C, Kim C, Leung K, Fung K, Tse T . Differential effect of Coriolus versicolor (Yunzhi) extract on cytokine production by murine lymphocytes in vitro. Int Immunopharmacol. 2004; 4(12):1549-57. DOI: 10.1016/j.intimp.2004.07.021. View

2.
Qian Z, Xu M, Tang P . Polysaccharide peptide (PSP) restores immunosuppression induced by cyclophosphamide in rats. Am J Chin Med. 1997; 25(1):27-35. DOI: 10.1142/S0192415X97000068. View

3.
Sakagami H, Aoki T, Simpson A, Tanuma S . Induction of immunopotentiation activity by a protein-bound polysaccharide, PSK (review). Anticancer Res. 1991; 11(2):993-9. View

4.
Coles M, Toth B . Lack of prevention of large intestinal cancer by VPS, an extract of Coriolus versicolor mushroom. In Vivo. 2005; 19(5):867-71. View

5.
Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K . Krestin (PSK). Cancer Treat Rev. 1984; 11(2):131-55. DOI: 10.1016/0305-7372(84)90005-7. View